{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:51:28Z","timestamp":1775872288373,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,22]]},"DOI":"10.7759\/cureus.104044","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T08:38:02Z","timestamp":1771749482000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Refractory Polyarticular Juvenile Idiopathic Arthritis Post-hematopoietic Stem Cell Transplantation Successfully Treated With Ruxolitinib"],"prefix":"10.7759","author":[{"given":"Yuta","family":"Sonehara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-445965","article-title":"New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation","volume":"121","author":"Daikeler T","year":"2013","unstructured":"Daikeler T, Labopin M, Ruggeri A, et al.. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2013, 121:1059-64. 10.1182\/blood-2012-07-445965","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.110","article-title":"Juvenile arthritis after haematopoietic stem cell transplantation","volume":"49","author":"Tronconi E","year":"2014","unstructured":"Tronconi E, Miniaci A, Prete A, Masetti R, Pession A. Juvenile arthritis after haematopoietic stem cell transplantation. Bone Marrow Transplant. 2014, 49:1244-5. 10.1038\/bmt.2014.110","journal-title":"Bone Marrow Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703664","article-title":"Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation","volume":"30","author":"Imamura R","year":"2002","unstructured":"Imamura R, Inoue H, Kato K, et al.. Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2002, 30:527-9. 10.1038\/sj.bmt.1703664","journal-title":"Bone Marrow Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.03.010","article-title":"The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation","volume":"39","author":"Barnabe CC","year":"2009","unstructured":"Barnabe CC, LeClercq SA, Fitzgerald AA. The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation. Semin Arthritis Rheum. 2009, 39:55-60. 10.1016\/j.semarthrit.2008.03.010","journal-title":"Semin Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-336156","article-title":"Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party","volume":"118","author":"Daikeler T","year":"2011","unstructured":"Daikeler T, Labopin M, Di Gioia M, et al.. Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party. Blood. 2011, 118:1693-8. 10.1182\/blood-2011-02-336156","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea JJ","year":"2012","unstructured":"O'Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 2012, 36:542-50. 10.1016\/j.immuni.2012.03.014","journal-title":"Immunity"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00754.x","article-title":"Janus kinases in immune cell signaling","volume":"228","author":"Ghoreschi K","year":"2009","unstructured":"Ghoreschi K, Laurence A, O'Shea JJ. Janus kinases in immune cell signaling. Immunol Rev. 2009, 228:273-87. 10.1111\/j.1600-065X.2008.00754.x","journal-title":"Immunol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser R","year":"2020","unstructured":"Zeiser R, von Bubnoff N, Butler J, et al.. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020, 382:1800-10. 10.1056\/NEJMoa1917635","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.406","article-title":"Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up","volume":"305","author":"Bartelds GM","year":"2011","unstructured":"Bartelds GM, Krieckaert CL, Nurmohamed MT, et al.. Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up. JAMA. 2011, 305:1460-8. 10.1001\/jama.2011.406","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2023.100195","article-title":"Optimal use of JAK inhibitors and biologics for atopic dermatitis on the basis of the current evidence","volume":"3","author":"Kamata M","year":"2023","unstructured":"Kamata M, Tada Y. Optimal use of JAK inhibitors and biologics for atopic dermatitis on the basis of the current evidence. JID Innov. 2023, 3:100195. 10.1016\/j.xjidi.2023.100195","journal-title":"JID Innov"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-023-00594-7","article-title":"Scope of Jak inhibitors in children: recent evidence and way forward","volume":"25","author":"Bagri NK","year":"2023","unstructured":"Bagri NK, Chew C, Ramanan AV. Scope of Jak inhibitors in children: recent evidence and way forward. Paediatr Drugs. 2023, 25:635-47. 10.1007\/s40272-023-00594-7","journal-title":"Paediatr Drugs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022565","article-title":"Ruxolitinib for pediatric patients with treatment-na\u00efve and steroid-refractory acute graft-versus-host disease: the REACH4 study","volume":"144","author":"Locatelli F","year":"2024","unstructured":"Locatelli F, Kang HJ, Bruno B, et al.. Ruxolitinib for pediatric patients with treatment-na\u00efve and steroid-refractory acute graft-versus-host disease: the REACH4 study. Blood. 2024, 144:2095-106. 10.1182\/blood.2023022565","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)00921-2","article-title":"Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial","volume":"402","author":"Ramanan AV","year":"2023","unstructured":"Ramanan AV, Quartier P, Okamoto N, et al.. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial. Lancet. 2023, 402:555-70. 10.1016\/s0140-6736(23)00921-2","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/459708-a-case-of-refractory-polyarticular-juvenile-idiopathic-arthritis-post-hematopoietic-stem-cell-transplantation-successfully-treated-with-ruxolitinib","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T08:38:03Z","timestamp":1771749483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/459708-a-case-of-refractory-polyarticular-juvenile-idiopathic-arthritis-post-hematopoietic-stem-cell-transplantation-successfully-treated-with-ruxolitinib"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.104044","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,22]]}}}